71
Participants
Start Date
June 30, 2007
Primary Completion Date
April 30, 2013
Study Completion Date
May 31, 2013
Dichlorphenamide (double-blind)
50mg tablet; maximum dosage 400mg/day
Placebo (double-blind)
Inactive substance manufactured to look like Dichlorphenamide 50mg tablet
Dichlorphenamide (open-label)
50mg tablet; maximum dosage 400mg/day
Columbia University Medical Center, New York
University of Rochester, Rochester
Ohio State University, Columbus
Mayo Clinic, Rochester
Washington University School of Medicine, St Louis
University of Kansas Medical Center, Kansas City
University of Texas Southwestern-Dallas, Dallas
UCLA Neurology, Los Angeles
University of California-San Francisco, San Francisco
Brigham & Women's Hospital, Boston
University of Milan, San Donato
Institute of Neurology-Queen's Square, London
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
University of Rochester
OTHER